October 8, 2020 Certara Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
October 1, 2020 Food and Drug Administration Renews and Expands Use of Certara’s Biosimulation Software for Reviewing Regulatory Submissions
August 13, 2020 Certara Announces First Enrollee in International Registry to Assess Preventative Therapies in Healthcare Workers Exposed to COVID-19
August 10, 2020 Certara Announces New COVID-19 Biosimulation Platform and Key Updates to Its Quantitative Systems Pharmacology (QSP) Technology Platforms